CDK2 and endometrial cancer: Despite the broad role of CDK2 in the cell cycle, only cluster 3, largely comprising of ovarian and endometrial cancer cell lines, exhibited exclusive vulnerability to CDK2 and CCNE1 depletion (Fig. 1A–C).